148 related articles for article (PubMed ID: 16382193)
1. Naloxone precipitates nicotine abstinence syndrome and attenuates nicotine-induced antinociception in mice.
Biała G; Budzyńska B; Kruk M
Pharmacol Rep; 2005; 57(6):755-60. PubMed ID: 16382193
[TBL] [Abstract][Full Text] [Related]
2. Repeated administration of nicotine attenuates the development of morphine tolerance and dependence in mice.
Haghparast A; Khani A; Naderi N; Alizadeh AM; Motamedi F
Pharmacol Biochem Behav; 2008 Feb; 88(4):385-92. PubMed ID: 17915302
[TBL] [Abstract][Full Text] [Related]
3. Nicotine withdrawal hyperalgesia and opioid-mediated analgesia depend on nicotine receptors in nucleus accumbens.
Schmidt BL; Tambeli CH; Gear RW; Levine JD
Neuroscience; 2001; 106(1):129-36. PubMed ID: 11564423
[TBL] [Abstract][Full Text] [Related]
4. Neurosteroids in nicotine and morphine dependence.
Concas A; Sogliano C; Porcu P; Marra C; Brundu A; Biggio G
Psychopharmacology (Berl); 2006 Jun; 186(3):281-92. PubMed ID: 16133140
[TBL] [Abstract][Full Text] [Related]
5. Involvement of cholinergic and opioid receptor mechanisms in nicotine-induced antinociception.
Zarrindast MR; Pazouki M; Nassiri-Rad S
Pharmacol Toxicol; 1997 Nov; 81(5):209-13. PubMed ID: 9396085
[TBL] [Abstract][Full Text] [Related]
6. Involvement of spinal Met-enkephalin in nicotine-induced antinociception in mice.
Kiguchi N; Maeda T; Tsuruga M; Yamamoto A; Yamamoto C; Ozaki M; Kishioka S
Brain Res; 2008 Jan; 1189():70-7. PubMed ID: 18048009
[TBL] [Abstract][Full Text] [Related]
7. Prohormone convertase 2 (PC2) null mice have increased mu opioid receptor levels accompanied by altered morphine-induced antinociception, tolerance and dependence.
Lutfy K; Parikh D; Lee DL; Liu Y; Ferrini MG; Hamid A; Friedman TC
Neuroscience; 2016 Aug; 329():318-25. PubMed ID: 27208618
[TBL] [Abstract][Full Text] [Related]
8. Nicotinic receptor involvement in antinociception induced by exposure to cigarette smoke.
Simons CT; Cuellar JM; Moore JA; Pinkerton KE; Uyeminami D; Carstens MI; Carstens E
Neurosci Lett; 2005 Dec; 389(2):71-6. PubMed ID: 16095820
[TBL] [Abstract][Full Text] [Related]
9. Reward and somatic changes during precipitated nicotine withdrawal in rats: centrally and peripherally mediated effects.
Watkins SS; Stinus L; Koob GF; Markou A
J Pharmacol Exp Ther; 2000 Mar; 292(3):1053-64. PubMed ID: 10688623
[TBL] [Abstract][Full Text] [Related]
10. Modulation of opioidergic system on mecamylamine-precipitated nicotine-withdrawal aversion in rats.
Ise Y; Narita M; Nagase H; Suzuki T
Psychopharmacology (Berl); 2000 Jul; 151(1):49-54. PubMed ID: 10958116
[TBL] [Abstract][Full Text] [Related]
11. Cross-tolerance between morphine- and nicotine-induced conditioned place preference in mice.
Zarrindast MR; Faraji N; Rostami P; Sahraei H; Ghoshouni H
Pharmacol Biochem Behav; 2003 Jan; 74(2):363-9. PubMed ID: 12479956
[TBL] [Abstract][Full Text] [Related]
12. SU-6656, a selective Src kinase inhibitor, attenuates mecamylamine-precipitated nicotine withdrawal syndrome in mice.
Rehni AK; Singh TG; Arora S
Nicotine Tob Res; 2012 Apr; 14(4):407-14. PubMed ID: 22102627
[TBL] [Abstract][Full Text] [Related]
13. Stereoselective action of (+)-morphine over (-)-morphine in attenuating the (-)-morphine-produced antinociception via the naloxone-sensitive sigma receptor in the mouse.
Wu HE; Hong JS; Tseng LF
Eur J Pharmacol; 2007 Oct; 571(2-3):145-51. PubMed ID: 17617400
[TBL] [Abstract][Full Text] [Related]
14. On the mechanism of cross-tolerance between morphine- and nicotine-induced antinociception: involvement of calcium channels.
Biala G; Weglinska B
Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jan; 30(1):15-21. PubMed ID: 16202496
[TBL] [Abstract][Full Text] [Related]
15. The role of nicotinic acetylcholine and opioid systems of the ventral orbital cortex in modulation of formalin-induced orofacial pain in rats.
Yousofizadeh S; Tamaddonfard E; Farshid AA
Eur J Pharmacol; 2015 Jul; 758():147-52. PubMed ID: 25864612
[TBL] [Abstract][Full Text] [Related]
16. Nicotine attenuates naloxone-induced jumping behaviour in morphine-dependent mice.
Zarrindast MR; Farzin D
Eur J Pharmacol; 1996 Feb; 298(1):1-6. PubMed ID: 8867912
[TBL] [Abstract][Full Text] [Related]
17. Morphine tolerance and dependence in the nociceptin receptor knockout mice.
Mamiya T; Noda Y; Ren X; Nagai T; Takeshima H; Ukai M; Nabeshima T
J Neural Transm (Vienna); 2001; 108(12):1349-61. PubMed ID: 11810400
[TBL] [Abstract][Full Text] [Related]
18. Tropisetron attenuates naloxone-induced place aversion in single-dose morphine-treated rats: role of alpha7 nicotinic receptors.
Cui R; Suemaru K; Li B; Kohnomi S; Araki H
Eur J Pharmacol; 2009 May; 609(1-3):74-7. PubMed ID: 19374878
[TBL] [Abstract][Full Text] [Related]
19. Blockade of the expression of mecamylamine-precipitated nicotine withdrawal by calcium channel antagonists.
Biala G; Weglinska B
Pharmacol Res; 2005 May; 51(5):483-8. PubMed ID: 15749464
[TBL] [Abstract][Full Text] [Related]
20. Dissociation of physical abstinence signs from changes in extracellular dopamine in the nucleus accumbens and in the prefrontal cortex of nicotine dependent rats.
Carboni E; Bortone L; Giua C; Di Chiara G
Drug Alcohol Depend; 2000 Feb; 58(1-2):93-102. PubMed ID: 10669059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]